Immunis Biomedical
Immunis is a clinical-stage biotechnology company targeting age-driven diseases to promote a healthier lifespan.
Series A ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 26, 2018 (8 years old)
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Website created
Companies like Immunis Biomedical
CCity TherapeuticsSeries B+ · Aug 2026
FFoRx Therapeutics$50M Series A · Dec 2025
VVaderis Therapeutics$152M Series B+ · Aug 2026
SStorm Therapeutics$56M Series B+ · Apr 2026
CComplement TherapeuticsSeries A · Apr 2023
IInnornaSeries B+ · Apr 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immunis-biomedical (get a free API key).